Sanofi at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Sanofi takes part in 4 sessions at ACT 2026 in San Antonio. Its program centres on embryofetal development testing, including how to set a study strategy, and on complex human-derived models as new approach methods. It also covers the safety and regulatory path for immune engagers.

Organization	ACT 2026 Attendance
Sanofi Paris, France	◇Bronze Supporter
sanofi.com Pharmaceutical companiesBronze Supporter French global biopharmaceutical company developing and marketing medicines and vaccines, with a strong emphasis on immunology.	Session Sun Nov 15 8:00am–11:30am The ABCs of EFDs: A Modern Guide to Embryofetal Development Testing (CE3) DART · with Otsuka 8:00amThe ABCs of EFDs Introduction (CE3-1)Otsuka 8:05amDesigning a EFD Study (CE3-2)Amgen 8:30amSetting the EFD Testing Study Strategy (CE3-3)Sanofi 9:00amConducting an EFD Study: The Essentials of Getting it Right (CE3-4)Johnson & Johnson 10:00amInterpreting EFD Study Data (CE3-5)Lilly 10:35amCommunicating EFD Study Results (CE3-6) Talk Sun Nov 15 8:30am–9:00am Part of The ABCs of EFDs: A Modern Guide to Embryofetal Development Testing (CE3) Setting the EFD Testing Study Strategy (CE3-3) DART Talk Sun Nov 15 2:00pm–2:30pm Part of Beyond Animal Models: Navigating New Approach Methodologies in Modern Drug Development with Case Study Examples (CE5) Complex Human-Derived Models as New Approach Methodologies (NAMs) for Drug Discovery and Development (CE5-4) New approach methods Session Mon Nov 16 2:00pm–5:00pm Safety and Regulatory Roadmap for Immune Engagers: Strategies to Translate Novel Modalities (S05) Biologics and new modalities · Regulatory · with AstraZeneca 2:00pmIntroduction (S05-1)AstraZeneca 2:05pmMechanistic Toxicity of Immune Engagers: From Bench to Clinic (S05-2)AstraZeneca 2:30pmTranslating NAMs to First-in-Human Dose Selection and Regulatory Acceptance (S05-3)Certara 2:55pmSafety Assessment of Immune Engagers for Autoimmune Disease: An FDA Perspective (S05-4)U.S. Food and Drug Administration 3:45pmChallenging Case Studies: Clinical Translation and Risk Management in Immune Engager Trials (S05-5)University of Liverpool

Organization

ACT 2026 Attendance

Sanofi

Paris, France

◇Bronze Supporter

sanofi.com

Pharmaceutical companiesBronze Supporter

French global biopharmaceutical company developing and marketing medicines and vaccines, with a strong emphasis on immunology.

Session

Sun Nov 15
8:00am–11:30am

The ABCs of EFDs: A Modern Guide to Embryofetal Development Testing (CE3)

DART · with Otsuka

8:00amThe ABCs of EFDs Introduction (CE3-1)Otsuka
8:05amDesigning a EFD Study (CE3-2)Amgen
8:30amSetting the EFD Testing Study Strategy (CE3-3)Sanofi
9:00amConducting an EFD Study: The Essentials of Getting it Right (CE3-4)Johnson & Johnson
10:00amInterpreting EFD Study Data (CE3-5)Lilly
10:35amCommunicating EFD Study Results (CE3-6)

Talk

Sun Nov 15
8:30am–9:00am

Part of The ABCs of EFDs: A Modern Guide to Embryofetal Development Testing (CE3)

Setting the EFD Testing Study Strategy (CE3-3)

DART

Talk

Sun Nov 15
2:00pm–2:30pm

Part of Beyond Animal Models: Navigating New Approach Methodologies in Modern Drug Development with Case Study Examples (CE5)

Complex Human-Derived Models as New Approach Methodologies (NAMs) for Drug Discovery and Development (CE5-4)

New approach methods

Session

Mon Nov 16
2:00pm–5:00pm

Safety and Regulatory Roadmap for Immune Engagers: Strategies to Translate Novel Modalities (S05)

Biologics and new modalities · Regulatory · with AstraZeneca

2:00pmIntroduction (S05-1)AstraZeneca
2:05pmMechanistic Toxicity of Immune Engagers: From Bench to Clinic (S05-2)AstraZeneca
2:30pmTranslating NAMs to First-in-Human Dose Selection and Regulatory Acceptance (S05-3)Certara
2:55pmSafety Assessment of Immune Engagers for Autoimmune Disease: An FDA Perspective (S05-4)U.S. Food and Drug Administration
3:45pmChallenging Case Studies: Clinical Translation and Risk Management in Immune Engager Trials (S05-5)University of Liverpool

Instantly find 20 buyers from Sanofi

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction